This topic contains a solution. Click here to go to the answer

Author Question: In comparison to pemoline (Cylert) and methylphenidate (Ritalin), atomoxetine (Strattera) may prove ... (Read 127 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
In comparison to pemoline (Cylert) and methylphenidate (Ritalin), atomoxetine (Strattera) may prove to:
 
  a. be less effective in the treatment of attention-deficit disorder
  b. worsen depression and cause suicidal ideation
  c. have less potential for abuse in susceptible individuals
  d. be more sedating and cause weight gain

Question 2

During a group session, one of the members states, Let's keep this discussion going so that everyone can participate, but let's keep the time each person speaks to about 3 minutes. The leader interprets this member as acting in which role?
 
  A) Group observer
  B) Gatekeeper
  C) Encourager
  D) Energizer



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raili21

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C
Strattera may prove to have less potential for abuse than Cylert or Ritalin. However, there appears to be an increased risk of suicidal ideations and liver disease for those taking Strattera, as opposed to Cylert or Ritalin.

Answer to Question 2

B




anjilletteb

  • Member
  • Posts: 569
Reply 2 on: Jul 19, 2018
Thanks for the timely response, appreciate it


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

For a complete list of videos, visit our video library